2021-01-24 17:55:05 Illumina因美纳(中国)科学器材有限公司
温馨提示
非常感谢大家对于本次会议的关注。由于本次会议场地有限,不能满足所有前期注册老师现场参会的需求。如果还没有收到现场参会通知的老师,我们深表歉意。同时,我们将尽快以短信的方式发送直播链接给您,确保您能获得本次会议的全程信息。
Building Cell Atlas,
Empowering Cellular Medicine
构建细胞图谱、赋能细胞医疗
人体是由基因组上的基本程序单元编码所形成的复杂系统。细胞是该系统的基本结构和功能单元,编码过程在其中得到执行。了解细胞的特点和行为对理解生命和疾病至关重要。单细胞基因组学和其他单细胞组学技术开启了生命科学的新时代,在全球构建人类细胞图谱工作的引领下,致力于定量分析所有细胞主要分子特征并了解它们之间的关系。这些工作将为今后研究人体机能,尤其是复杂疾病的细胞医学提供基础参考。首届中国单细胞基因组学峰会将于2019年5月25日在清华大学举行。届时,全球人类细胞图谱计划的领导者、中国单细胞生物学的顶尖科学家和业界技术领袖将齐聚一堂,分享该领域的最新进展和未来愿景。
Date: May 25, Saturday, 2019
Organizers: Tsinghua University,
Illumina, 10x Genomics
直播参会注册通道
Speakers, Panelists & Honored Guests
Aviv Regev
Broad Institute, USA
Aviv Regev, a computational and systems biologist, joined the Broad Institute as a core member and MIT as a faculty member in 2006. Regev’s research centers on understanding how complex molecular circuits function in cells and between cells in tissues. She is a professor in the Department of Biology at MIT, Chair of the Faculty and founding director of the Klarman Cell Observatory and Cell Circuits Program at the Broad, and an Investigator at the Howard Hughes Medical Institute. Her lab has been a pioneer of single-cell genomics–inventing key experimental methods and computational algorithms in the field, and demonstrating how to apply it to understand cell taxonomies, histological organization, differentiation and physiological processes, and how to infer the molecular and cellular circuits that control the function of cells and tissues in health and disease. She is the Founding Co-Chair of the international initiative to build a Human Cell Atlas (HCA), whose mission is to create comprehensive reference maps of all human cells—the fundamental units of life—as a basis for both understanding human health and diagnosing, monitoring, and treating disease.
Jie Qiao
Peking University Third Hospital, China
Jie Qiao, is Academician of Chinese academy of engineering, President and Chief Physician of Peking University Third Hospital, Director of the National Clinical Research Center on Obstetrics and Gynecology (OBYGN) Disease, President of China Women Doctors Association, Chair for the Reproductive Medical Society of Chinese Medical Doctor Association, Chief editor of Human Reproduction Update (Chinese version) and Special Consultant NEJM Medical frontier.
Her reproductive research focus on the molecular mechanism of human gametogenesis and embryo development, infertility causes and clinical treatments, the protection and preservation of female fertility as well as developing new pre-implantation diagnosis methods. Qiao has led the team to achieve a number of technical and theoretical breakthroughs in the systematic study of human embryonic development and team made many landmark contributions to the development of reproductive medicine. From 2016, about 600,000 outpatients visited Peking University Third Hospital ART Center every year. Up to now, she has published 199 SCI papers as the first or corresponding author, including Science, Cell, JAMA, Nature, Lancet, Nature Genetics etc, providing new insights into the mechanism of epigenetic regulation during embryonic development and bringing hope to a great number of infertile patients in China.
Xuegong Zhang
Tsinghua University, China
Prof. Xuegong Zhang earned his BS degree in Industrial Automation in 1989 and Ph.D. degree in Pattern Recognition and Intelligent Systems in 1994, both from Tsinghua University. He joined the faculty of Tsinghua University in 1994, where he is now a Professor of Pattern Recognition and Bioinformatics in the Department of Automation, and an Adjunct Professor of the School of Life Sciences and also the School of Medicine. Dr. Zhang worked at Harvard School of Public Health as a visiting scientist on computational biology in 2001-2002, and had been a visiting scholar in the MCB program at USC in 2007. He is the Director of the Bioinformatics Division, Beijing National Research Institute for Information Science and Technology (BNRist), and the Acting Director of the Tsinghua University Center for Systems and Synthetic Biology. His research interests include machine learning, biological data mining especially for single-cell sequencing data and metagenomic sequencing data, human cell atlas, and analyses of multi-modal big healthcare data for precision medicine.
Zemin Zhang
Peking University, China
Zemin Zhang is a Professor of Peking University and a principal investigator at BIOPIC, the Center for Life Sciences of Peking and Tsinghua Universities, and Beijing Advanced Innovation Center for Genomics. Dr. Zhang obtained his BS from Nankai University, PhD from Penn State University and postdoctoral trainings at UCSF. Dr. Zhang spent >16 years at Genentech/Roche, leading the cancer genomics and bioinformatics group to discover anticancer targets and biomarkers using cutting technologies such as machine learning and high throughput sequencing. He has pioneered multiple research directions in computational cancer biology and cancer genomics including the first ever whole genome tumor sequencing. He is also an inventor for 60 issued US patents and has directly contributed to the initial finding of the molecular targets of multiple cancer therapeutic agents in clinical trials. His lab currently focuses on understanding the interplay between immune and cancer cells using both large-scale cancer genomics data and the cutting-edge single cell sequencing technologies. He is a CUSBEA Scholar as well as Cheung Kong Scholar.
Muzlifah Haniffa
Newcastle University, UK
Muzlifah Haniffa is a Wellcome Trust Senior Research Fellow, Lister Institute Research Fellow and Consultant Dermatologist based in Newcastle University. She graduated from medical school in Cardiff and trained as a junior doctor in Cambridge. She received her dermatology specialist training in Newcastle. She was awarded an Action Medical Research Training Fellowship and a Wellcome Trust Clinical Intermediate Fellowship. Her research programme aims to understand the functional organisation of the developing and adult human immune system in health and disease.
Jonah Cool
Chan Zuckerberg Initiative, USA
Jonah Cool is a cell biologist and geneticist by training, and is currently a Science Program Officer at the Chan Zuckerberg Initiative, where he leads the organization''s efforts to support the international Human Cell Atlas consortium. He was an American Heart Association fellow while completing his PhD at Duke Medical Center, with a focus on the role of vascularization during cell differentiation and organ morphogenesis, and was subsequently a Ruth Kirchstein Fellow at the Salk Institute studying nuclear organization during stem cell differentiation. Dr. Cool previously worked in intellectual property litigation, as well as ran an industry research group working toward therapeutic application of 3D bioprinted human tissue. He has a deep love of cell biology and, in particular, the origins of cellular heterogeneity and how diverse cells assemble into complex tissues.
Xinrong Zhang
Tsinghua University, China
Xinrong Zhang was born in 1956. He received his Bachelor''s degrees at Shaanxi Normal University, China in 1982, and Ph.D degree at Ghent University, Belgium in 1997. His current research interests are focused on analytical methodology and application of mass spectrometry and luminescence analysis. He published over 190 papers in peer-reviewed journals and 10 patents related to analytical methods and instrumentation. He is now the RSC fellow and serves as Associate Editor of Analytical Chemistry (ACS), Editor-in-Chief of Luminescence (Wiley), Advisory Board Member of Talanta (Elsevier) and Analyst (RSC).
Guoji Guo
Zhejiang University, China
Professor Guoji Guo is the deputy director of Center for Stem Cell and Regenerative Medicine at Zhejiang University School of Medicine. He is also the deputy chair of Stem Cell Society at Zhejiang University. Professor Guoji Guo is interested in developing new single cell analysis technologies and applying these technologies to investigate stem cell biology.
Yinqing Li
Tsinghua University, China
Yinqing Li joined Tsinghua faculty in 2018 and is currently an assistant professor in the School of Pharmaceutical Sciences. He received his B.S. in microelectronics from Fudan University in 2008 and his S.M. and PhD in electrical engineering and computer science from Massachusetts Institute of Technology in 2012 and 2016. During the course of his doctoral and postdoctoral research, Yinqing pioneered the engineering and characterization of cell and gene editing tools, co-invented single-nucleus transcriptome profiling technologies, and broadened these tools to systematically interrogate cortical-thalamic circuity function and in disease models. His current research interests include single cell characterization and genome editing technologies.
Kristin Ardlie
Broad Institute, USA
Kristin Ardlie studies the functional impact of human genetic variation, and the regulation of gene expression. She lead the Genotype Tissue Expression (GTEx) Project''s, Laboratory, Data Analysis, and Coordinating Center (LDACC), producing and analyzing a resource of ~20,000 RNA-sequenced tissues from 960 donors with whole genome sequence data. She also works on RNA sequencing and analysis for the NHLBI''s TOPMed initiative, is part of the NIH''s Data Commons Pilot project, and serves as a program consultant on the external advisory board for the NIH/Common Fund''s Molecular Transducers of Physical Activity in Humans Consortium (MoTrPAC). Most recently she has worked single cell projects in the context of GTEx, including the development of open access consent documents, and extension of the GTEx pipeline for the enrollment of new donors for single cell project efforts. Kristin received a PhD from Princeton University in 1995, completed a fellowship with the Harvard Society of Fellows, and worked at the Whitehead Institute/MIT Center for Genome Research. She spent 6 years as VP of Genetics at Genomics Collaborative Inc.
Holger Heyn
National Centre for Genomic Analysis, Spain
Holger Heyn is the team Leader of the "Single Cell Genomics Group" at the Spain National Centre for Genomic Analysis (CNAG-CRG) . He focuses on the systematic integration of genomic data, to elucidate causalities underlying phenotype formation. The mission of the group is the development of novel genomics technologies and their application in a research context. Dr. Heyn published 61 peer-reviewed scientific papers (24 as first author or senior author), including 51 original research articles, 6 Reviews and 3 book chapters. These include publications in high-ranked scientific journals, such as Science, Cell, Nature Reviews Genetics, etc. The publications have been 4,872x cited, resulting in an h-index of 31 (Google Scholar). In 2014, he was awarded with the prestigious Miguel Servet fellowship to establish an independent research group. Since then, he obtained further competitive funding to support his work on Systems Genomics at the CNAG-CRG. He is participating in several national and international research consortia, including the Human Cell Atlas (HCA) Project, European Epigenome Project BLUEPRINT (IHEC) and The Cancer Genome Atlas (TCGA).
Sarion Bowers
Wellcome Trust Sanger Institute, UK
Sarion Bowers is the Head of Policy at the Wellcome Sanger Institute. She completed her PhD in Biochemistry at the University of Cambridge before continuing her research in DNA packaging and gene regulation in the UK and the US. She changed careers and now specialises in science and technology policy relating to genomics. Sarion has a particular interest UK science policy, data protection and the ethical, legal and societal issues that arise from the use of genomics, including genome editing.
Tao Dai
NHC, China
Tao Dai is in charge of PMI research projects, and translational medicine and he is researcher and research supervisor, actively involved in China health and medical system reform. His major research areas including health policy and administration, knowledge management and health informatics. He had been the Director of Health Informatics Institute of Chinese Academy of Medical Science, the Executive Deputy Director of the Center for Health Policy and Management Studies, and the Director of the Social Medicine and Health Administration Department of the Peking Union Medical College, etc.
Chen Dong
Tsinghua University, China
Dr. Dong is Professor and Director of the Institute for Immunology and also Dean of the School of Medicine at Tsinghua University, Beijing, China. Dr. Dong served as a Professor of Immunology and the Director of the Center for inflammation and Cancer at the University of Texas MD Anderson Cancer Center before his move to Tsinghua University. Dr. Dong''s research is to understand the molecular mechanisms whereby immune and inflammatory responses are normally regulated, and to apply this knowledge to the understanding and treatment of autoimmunity and allergy disorders as well as cancer. The work from Dr. Dong''s group has led to the discoveries of Th17 and T follicular helper (Tfh) cell subsets in the immune system and elucidation of their biological and pathological functions. Dr. Dong has over 200 publications and was rated highly cited researcher for five years from 2014 to 2018. The honors he has received include the 2009 American Association of Immunologists BD Bioscience Investigator Award and election of fellow, the American Association for the advancement of Science in 2011. He is currently an Editor for Immunity, Editor-in-chief for Frontiers in Immunology- T Cell Biology and Associate Editor for China Sciences- Life Sciences.
Michael Q. Zhang
UT Dallas/Tsinghua University, USA/China
Michael Q. Zhang got his B.S. in Mech. Eng. from USTC and joined the first CUSPEA (initiated by T.D. Lee) group studying physics in USA in 1981. After getting Statistical Physics PhD from Rutgers University in 1987, he became a postdoc at the Courant Institute of Mathematics at NYU until he became a Genome Research fellow at CSHL in 1991. He started my Computational Genomics Lab there in 1996 and became full professor in 2002. He became 1000-Talent guest professor of Tsinghua University in 2009 and moved to The University of Texas at Dallas as the Cecil H. and Ida Green Distinguished endowed chair Professor in 2010. He is currently the director of Center for Systems Biology at UT Dallas and the co-director of Center for Synthetic and Systems Biology at Tsinghua U.
Mayumi Kusunose
RIKEN, Japan
Mayumi Kusunose is a senior technical scientist at RIKEN. Her role entails providing ethical support for projects. She holds a master''s degree in Bioethics from the University of Pennsylvania and a master''s degree in Humanities and Social Sciences from Kochi University. Her professional interests include research ethics, clinical ethics and data ethics, with a particular focus on regenerative medicine, stem cell research, informed consent and benefit sharing.
Kevin Taylor
Illumina, USA
Assoc. Director, Cell Biology (Illumina, USA), Dr. Kevin Taylor earned his Ph.D. in Pathobiology and Molecular Medicine from the University of Cincinnati College of Medicine. He has held research positions at University of California - Irvine and the Cleveland Clinic''s Learner Research Institute focusing on the underlying signaling mechanisms that drive angiogenesis in development, tumor progression, and metastasis. Now, at Illumina, Kevin’s focus is on leveraging next generation sequencing methods for cell biology applications including single cell analysis.
Jenny XiaoIllumina, USA
Jenny Xiao is Associate Director, Global Market Development, for NGS genomic applications at Illumina. She currently focuses on developing KOL relationships and scientific society engagements in the field of Single cell and genome editing. Examples include participating NIST (National institute of standard and technology) genome editing consortium to develop standard control samples and off-target validation procedure and other government and society collaborations to address FDA''s safety concerns in genome editing based therapeutic solutions. Jenny completed her BS in Biology at Peking University, MBA at Santa Clara University and Ph.D. in Entomology at University of Hawaii at Manoa. After her postdoctoral training at Stanford Medical School, Jenny held different technical and commercial roles at Agilent Technologies, Agena, and Thermo Fisher Scientific with leading genomic technologies, including microarray, Mass-spec, real-time PCR, Sanger Sequencing, and NGS. She has worked with researchers in the field of molecular diagnostics, agricultural biotechnologies, and various research fields.
Jens Durruthy-Durruthy
10x Genomics, USA
Jens Durruthy Durruthy is the Product Manager for Single Cell at 10x Genomics. He oversees the various activities associated with managing the Single Cell Gene Expression Solution including the execution, development, and promotion of on-market and future single cell products. With over 8 years of experience working with various single cell technologies on and off the bench he is striving to deliver high quality single cell products. Jens holds a PhD in biomedical engineering from Stanford University. In his spare time, he enjoys running and traveling.
Agenda
9:00-9:10
Opening (Chair: Xuegong Zhang, Tsinghua University)
Honored Guests
Tao Dai(NHC),Chen Dong(Tsinghua)
Session 1. Overview
(Chair: Yinqing Li, Tsinghua University)
9:10-9:40
Aviv Regev, Broad Institute, USA
9:40-10:10
Muzz Haniffa, Newcastle University, UK
10:10-10:40
Xuegong Zhang, Tsinghua University, China
10:40-11:00
Group Photo & Tea Break
Session 2. Technology Development & Single-cell Profiling
(Chair: Xuegong Zhang, Tsinghua University)
11:00-11:30
Xinrong Zhang, Tsinghua University, China
11:30-12:00
Zemin Zhang, Peking University, China
12:00-12:30
Guoji Guo, Zhejiang University, China
12:40-13:50
Lunch Break
Session 3. Technology Development and Application in Medicine
(Chair: Michael Q. Zhang, UT Dallas / Tsinghua University)
14:00-14:30
Kevin Taylor, Illumina, USA
14:30-15:00
Jens Durruthy-Durruthy, 10x Genomics, USA
15:00-15:30
Jie Qiao, Peking University Third Hospital, China
15:30-15:50
Tea Break
Session 4. Standards, Ethics, Data Sharing and Global Collaboration
(Chair: Zemin Zhang, Peking University)
15:50-16:20
Jonah Cool, Chan Zuckerberg Initiative, USA
16:20-17:20
Panel discussion: Standards, Ethics, Data Sharing and Global Collaboration
Panelists
Zemin Zhang(Chair), Peking University, China
Michael Q. Zhang, UT Dallas/Tsinghua University, USA/China
Kristin Ardlie, Broad Institute, USA
Jonah Cool, Chan Zuckerberg Initiative, USA
Sarion Bowers, Wellcome Trust Sanger Institute, UK
Mayumi Kusunoses, RIKEN, Japan
Jenny Xiao, Illumina, USA
Yinqing Li, Tsinghua University, China
17:20
Closing Remarks
Xuegong Zhang, Tsinghua University, China
直播参会注册通道
请
07-01 英斯特朗
连载 | 药物一致性评价与粒度分析(三)07-01 欧美克仪器
【仪器百科】LS-909丨干湿二合一激光粒度分析仪07-01 欧美克仪器
标准物质解决方案 | PFASs(全氟及多氟化合物)06-29
第九期阿尔塔有约 | 环境专题【新污染物:PFAS】技术研讨会精彩回顾及提问解答06-29
“绿色技术范式”,分析化学未来发展方向——访中国分析测试协会副理事长、辽宁省分析科学研究院原院长刘成雁教授06-29 转载仪器信息网
华西医院-标准型数显脑立体定位仪、双通道体温维持仪、体式显微镜安装完成06-29 迈越生物
科鉴检测助力2家仪器企业获得首批产品可靠性认证证书06-28 科鉴检测
德国耶拿:锂电池生命周期分析解决方案06-28 德国耶拿
AI已来!生命科学本科教学如何紧跟技术浪潮06-28 Opentrons
盛瀚售后,五星级服务的秘诀是什么?06-28 SHINE
专为汽车制造商打造的柔性解决方案——实现制程控制06-28
西北工业大学-脑立体定位仪安装完成06-28 迈越生物
会议邀请 | 第九届海上检验医师论坛06-28
卓立要闻 | 创新发展ing…6月卓立“大事小情”速览06-28 光电行业都会关注
打造信任合作伙伴!2024年度卓立汉光客户满意度调查开启06-28 光电行业都会关注
如何挑选适用于三阶光学非线性的测量系统?Z扫描测量系统来助力!06-28 光电行业都会关注
招聘启事—中国科学院沈阳自动化研究所微纳光学测量表征技术课题组06-28 光电行业都会关注
谱育科技作为主要完成方 荣获2023年度国家科学技术进步一等奖和二等奖06-28 点击关注→
仪器原理丨顶空仪与吹扫捕集仪科普小知识06-28 天美色谱